Rockefeller Capital Management L.P. Galmed Pharmaceuticals Ltd. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.75 - $3.03 $61,983 - $107,319	-35,419 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$2.24 - $3.9 $2,307 - $4,017	-1,030 Reduced 2.83%	35,419 $107,000
Q4 2020 Feb 12, 2021	BUY	$3.06 - $4.17 $1,836 - $2,502	600 Added 1.67%	36,449 $113,000
Q3 2020 Nov 13, 2020	BUY	$3.46 - $5.69 $1,487 - $2,446	430 Added 1.21%	35,849 $126,000
Q4 2018 Feb 12, 2019	BUY	$6.59 - $14.47 $233,411 - $512,512	35,419 New	35,419 $242,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $67.7M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.